|
MechanismNK2R antagonists |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseDiscontinued |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with A. Menarini Research & Business Service GmbH
0 Patents (Medical) associated with A. Menarini Research & Business Service GmbH
100 Deals associated with A. Menarini Research & Business Service GmbH
100 Translational Medicine associated with A. Menarini Research & Business Service GmbH